celecoxib has been researched along with cyanidin-3-o-beta-glucopyranoside in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, W; Chen, T; Deng, L; He, Y; Hu, Y; Jiang, X; Jiao, R; Li, X; Ma, Y; Sun, J; Wu, S | 1 |
1 other study(ies) available for celecoxib and cyanidin-3-o-beta-glucopyranoside
| Article | Year |
|---|---|
Cyanidin-3-O-glucoside inhibits the UVB-induced ROS/COX-2 pathway in HaCaT cells.
Topics: Anthocyanins; Antioxidants; Apoptosis; bcl-X Protein; Celecoxib; Cell Line; Cyclooxygenase 2; ErbB Receptors; Glucosides; Humans; Keratinocytes; Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction; Ultraviolet Rays | 2017 |